In the context of RA, there was a pronounced decrease in the levels of GM-CSF and tumor necrosis factor-alpha (TNF-α), indicating a substantial reduction in pro-inflammatory cytokine production (Figure 3C). This evidence concerns the gene CSF2 and rheumatoid arthritis.